Rein Therapeutics (RNTX) Return on Assets [ROA] (2017 - 2026)
Rein Therapeutics (RNTX) reported Return on Assets [ROA] of -107.21% for Q2 2026, down 0.62 percentage points from -106.59% a year earlier but up 92.02 percentage points from the prior quarter.
Rein Therapeutics (RNTX) Return on Assets [ROA] (2017 - 2026) Analysis & Trends
For FY2025, Rein Therapeutics posted Return on Assets [ROA] of -115.62%, down 40.04 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of -19.88 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -75.59% in FY2024 (-50.16 pp), -25.43% in FY2023 (+53.02 pp), -78.44% in FY2022 (+3.64 pp) and -82.09% in FY2021 (+13.66 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of -199.23% in Q1 2026 and a high of -18.00% in Q1 2024.
- Year over year, Return on Assets [ROA] has now declined in each of the last seven quarters, with an average year-over-year change of -46.73 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q1 2024 (a gain of 105.77 percentage points); the low point was Q1 2026 (a drop of 93.21 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -199.23% (Q1 2026), -130.05% (Q4 2025) and -109.31% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Rein Therapeutics | 53.67 Mn | 53.67 Mn | - | -107.21% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -107.21% |
| Mar 31, 2026 | -199.23% |
| Dec 31, 2025 | -130.05% |
| Sep 30, 2025 | -109.31% |
| Jun 30, 2025 | -106.59% |
| Mar 31, 2025 | -106.02% |
| Dec 31, 2024 | -78.26% |
| Sep 30, 2024 | -27.72% |
| Jun 30, 2024 | -24.47% |
| Mar 31, 2024 | -18.00% |
| Dec 31, 2023 | -27.39% |
| Sep 30, 2023 | -102.11% |
| Jun 30, 2023 | -116.78% |
| Mar 31, 2023 | -123.77% |
| Dec 31, 2022 | -112.30% |
| Sep 30, 2022 | -97.57% |
| Jun 30, 2022 | -81.24% |
| Mar 31, 2022 | -63.19% |
| Dec 31, 2021 | -51.54% |
| Sep 30, 2021 | -41.60% |
Rein Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RNTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();